StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)

Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%

NeuroPace shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NeuroPace's shares outstanding was 34M at Jun 30, 2026. For fiscal 2025 it was 33M, up 12.3% from the year before. The highest annual figure on record is 33M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202533M+12.3%
FY2024Dec 31, 202429M+12.7%
FY2023Dec 31, 202326M+5.1%
FY2022Dec 31, 202225M+48.1%
FY2021Dec 31, 202117M+8038.9%
FY2020Dec 31, 20200M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202634M+3.8%
Q1 FY2026Mar 31, 202634M+7.1%
Q4 FY2025Dec 31, 202533M+11.6%
Q3 FY2025Sep 30, 202533M+12.5%
Q2 FY2025Jun 30, 202533M+13.9%
Q1 FY2025Mar 31, 202531M+11.3%
Q4 FY2024Dec 31, 202430M+11.6%
Q3 FY2024Sep 30, 202429M+13.2%
Q2 FY2024Jun 30, 202429M+13.3%
Q1 FY2024Mar 31, 202428M+12.7%
Q4 FY2023Dec 31, 202327M+8.0%
Q3 FY2023Sep 30, 202326M+5.2%
Q2 FY2023Jun 30, 202325M+4.0%
Q1 FY2023Mar 31, 202325M+3.2%
Q4 FY2022Dec 31, 202225M+2.4%
Q3 FY2022Sep 30, 202225M+2.6%
Q2 FY2022Jun 30, 202225M+39.6%
Q1 FY2022Mar 31, 202224M+8930.3%
Q4 FY2021Dec 31, 202124M+11495.6%
Q3 FY2021Sep 30, 202124M+11807.3%
Q2 FY2021Jun 30, 202118M+8573.0%
Q1 FY2021Mar 31, 20210M+33.0%
Q4 FY2020Dec 31, 20200M–
Q3 FY2020Sep 30, 20200M–
Q2 FY2020Jun 30, 20200M–
Q1 FY2020Mar 31, 20200M–

More NeuroPace figures

See a number that looks wrong?